Article
Heterogeneous expression of cytokines accounts for clinical diversity and refines prognostication in CMML.
Leukemia - 1 Jan 2019
Niyongere Sandrine, Lucas Nolwenn, Zhou Jun-Min, Sansil Samer, Pomicter Anthony D, Balasis Maria E, Robinson John, Kroeger Jodi, Zhang Qing, Zhao Yu Long, Ball Markus, Komrokji Rami, List Alan, Deininger Michael W, Fridley Brooke L, Santini Valeria, Solary Eric, Padron Eric
Abstract excerpt
Chronic myelomonocytic leukemia (CMML) is a clinically heterogeneous neoplasm in which JAK2 inhibition has demonstrated reductions in inflammatory cytokines and promising clinical activity. We hypothesize that annotation of inflammatory cytokines may uncover mutation-independent cytokine subsets associated with novel CMML prognostic features. A Luminex cytokine profiling assay was utilized to profile...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
